Peter Daley-Yates Selected Research

Peter Daley-Yates Research Topics

12	Asthma (Bronchial Asthma) 12/2023 - 10/2017
5	Chronic Obstructive Pulmonary Disease (COPD) 10/2023 - 01/2006
3	Inflammation (Inflammations) 01/2023 - 01/2006
2	Disease Progression 10/2023 - 10/2023
1	Respiratory Hypersensitivity 01/2021
1	Allergic Rhinitis 01/2012
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2012
1	Nausea 01/2006

9	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 10/2017
4	fluticasone furoate FDA Link 12/2023 - 09/2022
4	Bronchodilator Agents (Bronchodilators)IBA 10/2023 - 01/2018
2	Budesonide (Pulmicort)FDA LinkGeneric 12/2023 - 01/2023
2	vilanterolIBA 10/2023 - 09/2022
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023 - 01/2021
2	Formoterol Fumarate (Oxis)FDA Link 01/2023 - 01/2022
2	fluticasone furoate-vilanterol trifenatateIBA 09/2022 - 01/2018
2	SteroidsIBA 01/2018 - 10/2017
1	GoldIBA 10/2023
1	GSK573719IBA 10/2023
1	Cholinergic Agents (Cholinergics)IBA 10/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2022
1	GlucocorticoidsIBA 09/2022
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	batefenterolIBA 11/2018
1	Fluticasone (Cutivate)FDA LinkGeneric 10/2017
1	AllergensIBA 01/2012
1	SuspensionsIBA 01/2012
1	GSK 1004723IBA 01/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2012
1	CilomilastIBA 01/2006
1	Erythromycin (Erycette)FDA LinkGeneric 01/2006

5	Therapeutics 10/2023 - 01/2022
3	Drug Therapy (Chemotherapy) 10/2023 - 01/2018
1	Nebulizers and Vaporizers (Inhaler) 01/2018